JPRN-UMIN000015669已完成未知
Study to Determine the Optimal Starting Dose of FSH in a Low- Dose-Stepup Regimen - Study to Determine the Optimal Starting Dose of FSH in a Low- Dose-Stepup Regimen
Department of Obstetrics and Gynecology,Tokushima University Hospital0 个研究点目标入组 50 人开始时间: 2014年11月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)WHO group I ovarian failure (second-grade [central] amenorrhea) 2)WHO group III ovarian failure (ovarian amenorrhea) 3)Hyperprolactinemia
研究者
相似试验
进行中（未招募）
不适用
A Dose Targeted Phase I/II Study To Evaluate The Feasibility, Safety, And Biological Effects Of Intravenous Administration of A Wild-Type Reovirus (REOLYSIN®) in Combination With Paclitaxel and Carboplatin To Patients With Advanced MalignanciesAdvanced or metastatic solid tumours that are refractory to standard therapy or for which no curative standard therapy exists and for which paclitaxel plus carboplatin is appropriate palliative chemotherapy.MedDRA version: 8.1Level: LLTClassification code 10049280Term: Solid tumourEUCTR2006-006515-76-GBOncolytics Biotech Inc
已完成
不适用
Phase I study to optimize the safe starting dose of weekly paclitaxelhead and neck cancerJPRN-UMIN000020357Kanazawa University24
招募中
不适用
Investigation on the individualized starting dose of 6-mercaptopurine based on pharmacogeneticsKCT0006822Asan Medical Center90
招募中
不适用
A study to evaluate the optimal dose of FenuLife® (water soluble fiber) for assessment of its effect on occasional burning sensation and associated complaints1) Occasional burning sensation2) Upper abdomen discomfort3) Regurgitation4) Stomach fullnessDRKS00027126Frutarom Ltd.60
尚未招募
不适用
A clinical study to determine the optimal dose of WIN-1001X by evaluating its efficacy and safety in patients with early Parkinson’s diseaseDiseases of the nervous systemKCT0004536Medihelpline188